$AIP

AIP Stock Jumps To Record High – Here’s Why This Analyst Raised Their Price Target By Nearly 120%

Arteris, Inc. (AIP) shares hit a record high after reporting Q1 revenue of $22.9M, up 39% and beating estimates. Net loss was $1.2M, better than expected. Jefferies raised its price target to $35, citing AI-driven demand. Rosenblatt also increased its target to $38, noting data center wins. AIP stock has gained 116% this year.

Original reporting
Published Aug 21, 2026, 2:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 4:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AIP
Bullish
medium confidence
Mentioned
$AIP
Relevance
6/10
alphai data visualization · based on stocktwits.com
Decision brief

The 30-second read

$AIPBullishMed
01

Why it matters

Earnings beat and target raises could attract momentum traders, but watch operating loss guidance.

02

Market read

Micro‑cap AI‑related semiconductor IP stock showing strong earnings momentum.

03

What to watch

Potential slowdown in automotive IP revenue and reliance on a few large hyperscaler customers.

Relevance 6/10Novelty 7/10Timing: Wednesday

Background

Arteris is a semiconductor IP provider focusing on AI and data‑center markets.

Company-level read

Ticker impact

$AIPBullishMedium confidence
Context

Arteris reported Q1 revenue beat and analysts raised price targets, driving the stock to a record high.

Expected impact

Potential further rally if guidance holds, but watch for profitability concerns.

Evidence & confidence

Earnings beat is fresh news; however, small company size limits material impact.

Market effects

Highlights growing AI‑related royalty revenue in semiconductor IP space.

Limited to US micro‑cap investors.

Modest; reflects broader AI infrastructure demand.

Counterpoint

Profitability remains uncertain; higher targets may be premature.

Key entities

  • Arteris, Inc.

    Provider of semiconductor interconnect IP.

  • Jefferies

    Raised price target to $35.

  • Rosenblatt

    Raised price target to $38.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to

$HIMSHighAI 8/10

Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company

Hims & Hers (HIMS) CEO Andrew Dudum defended the company against an FTC lawsuit, citing its revenue growth and subscriber base. Q2 revenue rose 40% YoY to $753M, with a full-year forecast of $3.1B-$3.3B. However, margins fell to 64% from 76%, and free cash flow was negative $68M, raising concerns about profitability and legal risks.